Litigation Capital Management Ltd. — Share Issue/Capital Change 2021

Oct 18, 2021

National Storage Mechanism | Additional information

RNS Number : 3917P

Litigation Capital Management Ltd

18 October 2021

18 October 2021

Litigation Capital Management Limited

("LCM" or the "Company")

Issue of Equity and Total Voting Rights

Litigation Capital Management Limited (AIM:LIT), a leading international provider of litigation financing solutions, announces that that it has allotted and issued 498,583 ordinary shares in the Company pursuant to the conversion of partly paid shares at $0.17 per share. 

The Company has made an application for the 498,583 Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective at 8.00 a.m. on 22 October 2021. Following Admission, the Company will have 116,586,507 Ordinary Shares in issue, each with voting rights, which figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The Company does not hold any Ordinary Shares in Treasury.

- ENDS -

Enquiries

Litigation Capital Management	c/o Alma PR
Patrick Moloney, Chief Executive Officer
Canaccord (Nomad and Joint Broker)	Tel: 020 7523 8000
Bobbie Hilliam
Investec Bank plc (Joint Broker)	Tel: 020 7597 5970
David Anderson
Alma PR	Tel: 020 3405 0205
Justine James Susie Hudson	[email protected]
Kieran Breheny

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAEEPFEFFFFA